Zara Khan Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2018

Activation of p53 and destabilization of androgen receptor by combinatorial inhibition of MDM2 and MDMX in prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zara Khan Research Topics

Disease

2	Spinal Cord Injuries (Spinal Cord Injury) 05/2017 - 07/2015
1	Breast Neoplasms (Breast Cancer) 01/2024
1	Sarcoidosis (Schaumann Disease) 11/2023
1	Fatigue 11/2023
1	Triple Negative Breast Neoplasms 12/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Stroke (Strokes) 09/2016
1	Atrial Fibrillation 09/2016

Drug/Important Bio-Agent (IBA)

1	ReninIBA 01/2024
1	Angiotensin IIIBA 01/2024
1	AngiotensinsIBA 01/2024
1	CytokinesIBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	Mitochondrial DNA (mtDNA)IBA 11/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	LigandsIBA 11/2023
1	XI-006IBA 01/2018
1	nutlin 3IBA 01/2018
1	AndrogensIBA 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 09/2016
1	Peptides (Polypeptides)IBA 07/2015
1	HydrogelsIBA 07/2015

Therapy/Procedure

4	Therapeutics 01/2018 - 07/2015
1	Immunotherapy 12/2022
1	Castration 01/2018
1	Drug Therapy (Chemotherapy) 09/2016